Treatments of mood disorders
- Created by: Jess
- Created on: 28-01-14 19:37
View mindmap
- Treatments of mood disorders
- Biological treatments
- unipolar depression
- MAOI's - stop the secretion MAO's which is an enzyme that breaks down neurotransmitters and increase levels of seretonin
- these are toxic which means suicidal risks
- SSRI's - allow serotonin to remain active for longer in the synapse
- side effects of nausea
- Tricyclic antidepressents - prevent the reuptake of seretonin to increase the activity
- ECT - a brain seizure by passing an electric current through the brain
- memory loss and have 80% relapse rates. They also only alleviate depression for a short period of time
- MAOI's - stop the secretion MAO's which is an enzyme that breaks down neurotransmitters and increase levels of seretonin
- Bipolar
- Lithium carbonate - this normalizes the levels of neurotransmitters
- blurred vision or lack of conentration
- Lithium carbonate - this normalizes the levels of neurotransmitters
- Evaluation
- Drug therapies work better when they are combined with other treatments such as cognitive
- They don't help deal with stressful life events which are the cause of depression
- not all patients respond to the treatments
- unipolar depression
- Cognitive Treatments
- aims to challenge the negative schema of the client to become more positive
- Beck: aims to change the cognitive triad
- 1. increase confidence
- 2. challenge negative thoughts
- 3. identify negative thoughts
- 4. change key beliefs
- Rational emotional therapy
- aims to replace irrational thoughts with rational ones
- makes the sufferer aware of their thinking
- Hollon: compared effectiveness of cognitive and treaments and found relapse rates of 40% and 45%
- Evaluation
- The therapy will only work if the individual is motivated and articulate
- A combination of drugs and cognitive may be more effective
- less successful in the treatment of maina
- It can be used one to one or in small grops so its cost effective
- Biological treatments
Comments
No comments have yet been made